Protalix BioTherapeutics (PLX) Raw Materials (2011 - 2026)
Protalix BioTherapeutics (PLX) reported Raw Materials of $6.08 million for Q2 2026, up 39.6% from $4.36 million a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Raw Materials (2011 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics posted Raw Materials of $5.98 million, up 31.5% from FY2024.
- Raw Materials has increased for four consecutive years, with a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- By year, Raw Materials came in at $4.55 million in FY2024 (+8.9%), $4.18 million in FY2023 (+19.0%), $3.51 million in FY2022 (+10.8%) and $3.17 million in FY2021 (-5.4%).
- The Q2 2026 figure ranks as the highest quarterly Raw Materials in data going back to Q4 2011.
- Year over year, Raw Materials has now increased in each of the last eight quarters, with growth averaging 18.2% over the last eight quarters.
- The high point for year-over-year Raw Materials in five years was Q1 2023 (growth of 40.5%); the low point was Q3 2021 (a decline of 19.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.01 million (Q1 2026), $5.98 million (Q4 2025) and $4.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.08 Mn |
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 5.98 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 4.02 Mn |
| Dec 31, 2023 | 4.18 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.31 Mn |
| Dec 31, 2022 | 3.51 Mn |
| Sep 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 3.07 Mn |
| Dec 31, 2021 | 3.17 Mn |
| Sep 30, 2021 | 3.17 Mn |
API Access
Protalix BioTherapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();